Skip to content
Search

Latest Stories

Whooping cough outbreak in England: 9 infant deaths in six months

Whooping cough outbreak in England: 9 infant deaths in six months

A combination of factors, including a decline in vaccination uptake, is believed to be contributing to the rise in the cases.

Whooping Cough Outbreak

A total of 7,599 whooping cough cases have been recorded in England from January to May 2024, according to new data released by the UK Health Security Agency (UKHSA).


In January 2024, there were 555 cases, followed by 920 in February, 1,427 in March, 2,106 in April, and 2,591 in May.

While the majority of cases (over 53 per cent) occurred in individuals aged 15 years or older, who typically experience milder symptoms, a significant number (262) were reported in babies under 3 months old, who are at the highest risk of severe complications and death from whooping cough.

Since the outbreak began in November last year, there have been nine infant deaths (one in December 2023 and eight between January and May 2024).

Whooping cough, or pertussis, is a bacterial infection affecting the lungs. This cyclical disease peaks every 3 to 5 years, with the last increase seen in 2016.

A combination of factors, including a decline in vaccination uptake, is believed to be contributing to the rise in whooping cough cases.

The latest UKSHA data showed a continued decline in uptake for the vaccination offered to pregnant women to protect newborns against whooping cough, with coverage in March 2024 at 58.9 per cent, down from its peak of 72.6 per cent in March 2017.

“Vaccination is the best defence against whooping cough,” said Dr Mary Ramsay, Director of Immunisation at UK Health Security Agency, stressing the importance of timely vaccination during pregnancy and in childhood.

Pregnant women are offered a whooping cough vaccine during each pregnancy, ideally between 20 and 32 weeks.

According to Dr Ramsay, pregnant women are offered a whooping cough vaccine in every pregnancy, ideally between 20 and 32 weeks.

“This passes protection to their baby in the womb so that they are protected from birth in the first months of their life when they are most vulnerable and before they can receive their own vaccines,” Dr Ramsay said.

Timely vaccination during pregnancy has proven to provide 92 percent protection against infant death.

All babies are given three doses of the 6-in-1 jab at 8, 12 and 16 weeks of age to protect against whooping cough and other serious diseases such as diphtheria and polio, with a pre-school booster offered at 3 years 4 months.

“With cases continuing to rise and sadly 9 infant deaths since the outbreak began last November, ensuring women are vaccinated appropriately in pregnancy has never been more important,” Dr Ramsay noted.

Kate Brintworth, Chief Midwifery Officer for England, said the NHS is identifying areas at greater risk and implementing robust local vaccination programmes.

She urged pregnant women to get vaccinated to help protect their babies, citing Women can access the vaccine, which also protects against diphtheria and tetanus, through their GP or some antenatal services.

She has urged pregnant women to get vaccinated to help protect their babies, noting that women can access the vaccine, which also protects against diphtheria and tetanus, through their GP or some antenatal services.

“Parents should also ensure that their children get protected in the first few months after birth as part of the routine NHS vaccine offer,” Brintworth added.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less